Publication | Closed Access

Intraperitoneal administration of cisplatin plus bevacizumab for the management of malignant ascites in ovarian epithelial cancer: results of a phase III clinical trial

Intraperitoneal AdministrationMedicineCancer ManagementGynecologyOvarian Epithelial CancerCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian CancerMalignant Ascites